Pharm Tech Agenda 2014.06.12

From IHE Wiki
Jump to navigation Jump to search

09:30 - 09:45 Welcome

  • Participants
  • Review and Approve Agenda
  • Approval of minutes of TCon May 22, 2014

09:45 - 11:15 CP processing

  • The following (simple) CPs will be asked for approval WITHOUT reviewing them in detail (unless concrete comments are given):
  • CP-PHARM-068, Add more samples to Active Ingredient structure
  • CP-PHARM-069, Add terms to glossary
  • CP-PHARM-070, Align Purpose and Scope to Glossary
  • CP-PHARM-071, Improve definition of "Patient instructions" and "Fulfillment instructions"
  • CP-PHARM-072, Pharmacy Common Editorial Changes
  • CP-PHARM-075, Clarify meaning of statusCode
  • CP-PHARM-076, Renaming of chapters to align to naming policy
  • CP-PHARM-077, Adding Narrative Text element to supply element
  • CP-PHARM-079, Added missing “Specialty” to Data Element Specification
  • CP-PHARM-080, Correction to CP-PHARM-046 and CP-PHARM-047
  • CP-PHARM-081, Improve descriptions of Documents, Sections and Entries

They are either very short or pretty trivial -> Please prepare to these CPs by reviewing them in advance to determine if you have questions or comments. Otherwise approval is assumed.

  • Motion: Approve above block of CPs as "Approved for ballot"
  • Approved


  • The following (complex) CPs will be reviewed in detail and asked for approval:
  • CP-PHARM-063, Introduce a “Dosing Information” Content Module and restructure the PRE, PADV, DIS documents to reference this Content Module for Dosing Information
  • CP-PHARM-065, Enhance Medication packaging structure (asSuperContent, expirationDate)
  • Approved with addition that lotNumber will be moved one level higher
  • CP-PHARM-066, Add new status: "SUSPEND"
  • Approved
  • CP-PHARM-067, Clarify meaning of "Amounts of consumable to be dispensed" and "Quantity supplied" in the context of medicinal products containing multiple active ingredients
  • Approved
  • CP-PHARM-073, Make PADV capable to record also other kind of concerns than just ones caused by other Prescription-/ or Dispense items (e.g., by Allergy, etc.)
  • Approved
  • CP-PHARM-074, Introduce effectiveTime to specify the time the “code” (e.g. CANCEL) of the PADV shall become effective
  • Approved
  • CP-PHARM-078, Adding Status Code element to supply element to indicate whether this Dispensation Item is “partially” or “fully” fulfilling an underlying Prescription Item
  • Approved (will be elaboration until tomorrow for final review)
  • CP-PHARM-082, Add Pharmaceutical Adviser / Dispenser at section level (to be consistent with PRE)
  • Approved
  • CP-PHARM-083, Add additional constraints to underlying PCC Medications template
  • Approved
  • CP-PHARM-084, Add additional constraints to underlying PCC Supply template
  • Approved
  • CP-PHARM-085, Lower constraint for referenced PADV from SHALL to SHALL IF KNOWN
  • Approved


These CPs are either introducing an important change or require thorough review. We will discuss them in detail, but it’s important that you have studied the content in advance to increase our efficiency at the F2F.



11:15 - 11:45 Break

11:45 - 13:30 Medication Management (Michael/Stephen)

13:30 - 14:30 Lunch

14:30 - 15:15 Extending Pharmacy Whitepaper Admission/Discharge (Michael)

  • Discussion
    • Document FTP...

15:15 - 15:45 Updates to HMW (Jose)

  • Discussion

15:45 - 16:15 Medication Catalog (e.g. Formulary) (Jose/Simon)

  • Discussion

16:15 - 16:45 Update on Healthcare Product Supply Interoperability (Jose)

16:45 - 17:15 Break

17:15 - 18:00 Pharmacy Medication List (Jürgen)

  • Public Comment processing
  • Approval as new profile